Clinical mycophenolic acid monitoring in liver transplant recipients.
about
Cardiovascular risk after orthotopic liver transplantation, a review of the literature and preliminary results of a prospective studyA Rationale for Age-Adapted Immunosuppression in Organ TransplantationTherapeutic drug monitoring of mycophenolate in adult solid organ transplant patients: an update.The evaluation of enteric-coated mycophenolate sodium in cardiac deceased donor liver transplant patients in China.
P2860
Clinical mycophenolic acid monitoring in liver transplant recipients.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Clinical mycophenolic acid monitoring in liver transplant recipients.
@en
type
label
Clinical mycophenolic acid monitoring in liver transplant recipients.
@en
prefLabel
Clinical mycophenolic acid monitoring in liver transplant recipients.
@en
P2860
P1476
Clinical mycophenolic acid monitoring in liver transplant recipients.
@en
P2093
P2860
P304
10715-10728
P356
10.3748/WJG.V20.I31.10715
P407
P577
2014-08-01T00:00:00Z